The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory Infections.

Tal-Singer, Ruth; Miller, Bruce E; Rommes, Jean M; Luttmann, Mark A; Demaison, Christophe; Bradley Drummond, M; Pasquale, Cara B

Tal-Singer, Ruth; Miller, Bruce E; Rommes, Jean M; Luttmann, Mark A; Demaison, Christophe; Bradley Drummond, M; Pasquale, Cara B.

Afiliação

Tal-Singer R; COPD Foundation, COPD360Net, Washington DC, USA.
Miller BE; COPD Foundation, COPD360Net, Washington DC, USA.
Rommes JM; COPD Foundation, COPD360Net, Washington DC, USA.
Luttmann MA; COPD Foundation, COPD360Net, Washington DC, USA.
Demaison C; ENA Respiratory Pty Ltd, Sydney, Australia.
Bradley Drummond M; Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Pasquale CB; COPD Foundation, COPD360Net, Washington DC, USA.

J Patient Exp ; 10: 23743735231151554, 2023.

Article em En | MEDLINE | ID: mdl-36741822

Palavras-chave

COPD; antiviral; community survey; drug development; exacerbation; patient-centric; respiratory; viral infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Patient Exp Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google